Historical photo og Alfonse J. Muto

A TRADITION OF EXCELLENCE

Owned by family.
Driven by values.

Pine Pharmaceuticals began in early 1985 as Pine Pharmacy, a family-owned compounding pharmacy in Western New York. While our business has changed over the years, our values have not. No matter how much we grow, our top priority will always be delivering exceptional services and uncompromising quality with every order.

Celebrating 10 years of excellence.
A history of Pine’s journey.

 

Pine Pharmaceuticals is celebrating 10 years of excellence.

 

2014
Pine Pharmaceuticals | Decade of 503B Operations | Al and Alfonse Muto
2014

Pine Pharmaceuticals is Established

Alfonse Muto and Alfonse J. Muto, Pharm.D. register with the FDA shortly after the passage of Section 503B under the FD&C Act, establishing Pine Pharmaceuticals in a 5,000 sq. ft. facility.

2015
Pine Pharmaceuticals | Decade of 503B Operations | Ophthalmology Products
2015

New Therapeutic Offerings

Pine continues its growth within the industry by launching six products addressing new therapeutic areas, expanding its impact on patient care.

2016
Pine Pharmaceuticals | Decade of 503B Operations | Ophthalmology Innovation
2016

Pine Partners with ASCs

Pine releases six new ophthalmology products, enhancing its ability to partner with ambulatory surgery centers.

2017
Pine Pharmaceuticals | Decade of 503B Operations | Ophthalmology Droppers and Syringes
2017

Additional Custom Compounds

Pine diversifies its catalog with five additional custom compounds, offering physicians new ready-to-use options to address individual patient needs more effectively.

2018
2018

New cGMP-Compliant Facility

Pine unveils a new 25,000 sq. ft. cGMP-compliant facility, doubling its previous facility size and workforce and paving the way for the launch of four new products. 

2020
Pine Pharmaceuticals | Decade of 503B Operations | Facility Timeline
2020

Providing Aid During the Pandemic

Pine aids in the COVID-19 pandemic relief efforts, supplying hand sanitizer nationwide. 

2021
2021

Pine Adds 50,000 sq. ft. Expansion

Pine triples in size with a 50,000 sq. ft. expansion, enabling additional manufacturing, quality control, and warehousing capabilities. This growth strengthens its ability to address drug shortages and meet increasing demand.

2023
Pine Pharmaceuticals | Decade of 503B Operations | Hospital Products
2023

Strengthening Support for Hospital Systems

Pine expands its presence in the hospital market, introducing nine ready-to-administer IV bags. A new quality control lab is also established, enhancing its in-house testing capabilities.

Present
Pine Pharmaceuticals | Decade of 503B Operations | Facility 2024
Present

Continuing Excellence

Pine launches its first patient-facing compound, ComplEYEâ„¢ MDB, expanding its portfolio to over 50 products. Today, Pine partners with hospitals, surgery centers, and specialty practices nationwide, distributing millions of units yearly.

Leadership

Pine leadership: Alfonse J. Muto, PharmD and Alfonse Muto R.Ph

Alfonse J. Muto, Pharm.D.
Owner

Alfonse Muto, Pharmacist
Owner

Executive Team

James Ando, Pharm.D.
Manager – Innovation and Development

Joette DiPerna, Pharm.D.
Manager – MQA

Allison Gentile, Pharm.D.
Director of Pharmacy Services and Regulatory Affairs

Gayle Gleason
Director of Quality

Vanessa Mastrorilli, Pharm.D.
Manager – Supply Chain and Distribution

Christopher McArdell, MBA
Director of Marketing

Diana Mulholland
Director of Business Development

Morgan Morreale, CPA
Controller

Brent Standage
Director of Production